2023年7月29日

同时,目标将与斯坦福大学医学合作验证其诊断内窥镜AI。奈塞获得美国食品及药物管理局的510 (k)对子宫肌瘤映射技术印度femtech奈塞医学技术获得了美国食品和药物管理局510 (k)间隙肌瘤映射工具。子宫肌瘤映射评论家应用介入协助诊断和规划程序子宫肌瘤患者。它生成的3 d模型从超声图像,医生可以定位肌瘤子宫及其维度。目标与斯坦福大学医学验证其内镜AI东京启动人工智能医疗服务(AIM)签署了一项与斯坦福大学医学院联合研究协议,验证其诊断内窥镜AI。合作打算检查日本内窥镜AI的适用性在美国,有26000新发病例胃每年诊断出癌症。一份新闻稿中指出,在移民人口发生率特别高,尤其是东亚人。中国MedGPT声称实用诊断精度高中国数字医疗公司Medlinker最近着手检查医疗大规模语言模型的准确性MedGPT服务通过比较与人类医生的诊断能力。介绍了今年5月,MedGPT提供智能诊断和治疗能力,在实际医疗场景中提供实际的诊断价值。它也可以诊断疾病以外的领域的专业知识和建议基于其他临床观察和治疗计划的因素。 Its live evaluation involved 120 patients and ten doctors from West China Hospital, Sichuan University. Based on the review of their results by seven doctors from major Chinese hospitals, human doctors scored 7.5 out of 10 on average while MedGPT was graded 7.2. The recommendations provided by MedGPT were found to be 96% as good as the human doctors. Lunit to power breast cancer screening at major Saudi hospital South Korean medical AI company Lunit has bagged another contract in Saudi Arabia to deliver its AI solution for cancer diagnosis. According to a press release, the company signed a contract with Cloud Solutions, a subsidiary of Dr Sulaiman Al Habib Medical Group (HMG), which is one of the biggest healthcare providers in the Middle East. Lunit will supply its AI-powered mammography solution, Lunit INSIGHT MMG, to HMG for the next three years. It will be integrated into the diagnosis systems of its 20 medical institutions in the region. The partners will also collaborate to enhance the diagnostic support solution using Cloud Solution's cloud AI platform. The new contract closely follows the recent signing of a similar supply deal with Seha Virtual Hospital . Both contracts are expected to contribute to the kingdom's national cancer screening programme. Meanwhile, Lunit will also supply the Lunit INSIGHT DBT, its AI-powered 3D Breast Tomosynthesis analysis solution, to HMG later this year. Tags: